Mazen Animal Health - Oral Vaccines Revenue and Competitors
Estimated Revenue & Valuation
- Mazen Animal Health - Oral Vaccines's estimated annual revenue is currently $1.8M per year.
- Mazen Animal Health - Oral Vaccines's estimated revenue per employee is $77,500
Employee Data
- Mazen Animal Health - Oral Vaccines has 23 Employees.
- Mazen Animal Health - Oral Vaccines grew their employee count by 44% last year.
Mazen Animal Health - Oral Vaccines's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Research and Development | Reveal Email/Phone |
3 | Quality Director | Reveal Email/Phone |
4 | Director Finance | Reveal Email/Phone |
5 | Director Regulatory Affairs | Reveal Email/Phone |
6 | Field Manager - California | Reveal Email/Phone |
7 | Senior Research Scientist | Reveal Email/Phone |
8 | Research Scientist, Molecular Biologist | Reveal Email/Phone |
9 | Business Administration Lead | Reveal Email/Phone |
10 | Senior Principal Scientist, Biochemistry Lead | Reveal Email/Phone |
Mazen Animal Health - Oral Vaccines Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | -14% | N/A | N/A |
#2 | $16.1M | 104 | 9% | N/A | N/A |
#3 | $0.8M | 10 | -44% | $2.1M | N/A |
#4 | $504.4M | 2034 | 1% | $31.2M | N/A |
#5 | $8.1M | 52 | 6% | N/A | N/A |
#6 | $2M | 13 | 0% | N/A | N/A |
#7 | $0.3M | 2 | -85% | N/A | N/A |
#8 | $0.2M | 1 | 0% | N/A | N/A |
#9 | $1.8M | 23 | 44% | N/A | N/A |
#10 | $1.4M | 9 | -10% | N/A | N/A |
What Is Mazen Animal Health - Oral Vaccines?
Mazen Animal Health, Inc. is a biotechnology company transforming corn seed into the future of animal vaccines. We have produced proof of efficacy data in two vaccine candidates, each addressing a significant unmet need. By creating vaccines to be delivered orally with animal feed, Mazen provides elegant solutions to the challenges associated with injectable vaccines with:(1) increased production system ROI - removing the economic thresholds that control the vaccination decision today; (2) a safer method of vaccine administration for both animals and workers; (3) optimized vaccine efficacy allowing for reduced antibiotic use; and (4) vaccines with a global reach because of ambient temperature stability and ease of delivery. Mazen’s platform technology expresses antigens in corn seed and improves the standard vaccine manufacturing cost structure. These safe subunit antigen vaccines protect the animal by creating both mucosal and systemic immunity which should increase efficacy compared with current injectable vaccines. Corn seed containing antigen is ground into meal and added to animal feed. Cost effective disease prevention benefits the environment with decreased losses and increased productivity of protein to feed our planet. For more information, visit us at www.mazenanimalhealth.com, or follow us on Twitter at twitter.com/mazenanimal.
keywords:N/AN/A
Total Funding
23
Number of Employees
$1.8M
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.3M | 23 | N/A | N/A |
#2 | $4.3M | 23 | 10% | N/A |
#3 | $2.3M | 23 | 15% | N/A |
#4 | $4.7M | 23 | -48% | N/A |
#5 | $2.4M | 24 | N/A | N/A |